Document is current
Any future updates will be listed below
-
Authors
Ke, Yifeng
Zhao, Yingxiang
Feng, Qiang
Xue, Min
Zhang, Mingxuan
Tan, Liangzhang
Ren, Xinjun
-
Funding
Funding for this research was provided by:
Tianjin Health Research Project (TJWJ2023MS010)
Key Project of Natural Science in Colleges and Universities of Anhui Province (2022AH052324)
National Natural Science Foundation of China (82160202)
- License Information
-
More Information
Article History
Received: 23 May 2025
Accepted: 15 May 2026
First Online: 2 June 2026
Declarations
:
: The project “Research on Dopamine-Induced Differentiation of Pluripotent Stem Cells into Retinal Pigment Epithelium for the Treatment of Retinal Degenerative Diseases (TJYY2022120241)” was approved by the Animal Care and Use Committee of Tianjin Medical University Eye Hospital (May 21, 2023). Human iPSC line 30HU-002 used in this study were obtained commercially from iXCells Biotechnologies( ). According to documentation provided by the supplier, the original human tissue samples used to derive the iPSC line were ethically sourced, IRB-approved human tissue or blood samples with full regulatory compliance ( ). The cells were used under the terms and conditions of the supplier, and all research complied with institutional ethical standards for use of commercially sourced human cell products.
: All necessary consent and approvals were obtained from all authors and co-authors.
: The authors declare no competing interests.
